ARTICLE
26 December 2019

PMPRB Extends Deadline For Consultation On Draft Guidelines To January 31, 2020

SB
Smart & Biggar
Contributor
Smart & Biggar is Canada's largest firm practicing exclusively in intellectual property and technology law, with offices in Ottawa, Toronto, Montréal, Vancouver and Calgary. We are leaders in intellectual property and have been serving clients for over a century. Intellectual property rights are only valuable if they can be protected and exploited intelligently. At Smart & Biggar we are devoted to maximizing the value of our clients' intellectual property and technology assets. While we are proud that we have been selected repeatedly as Canada's leading intellectual property firm in numerous Canadian and international surveys, we recognize that our success is best measured by your success. Smart & Biggar operates as part of the IPH Limited group, under its own brand and independent from other IPH member firms. For more information, please visit https://www.smartbiggar.ca/
On November 21, 2019, the Patented Medicine Prices Review Board (PMPRB) released draft Guidelines operationalizing the recent amendments to the Patented Medicines Regulations for consultation
Canada Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

On November 21, 2019, the Patented Medicine Prices Review Board (PMPRB) released draft Guidelines operationalizing the recent amendments to the Patented Medicines Regulations for consultation (see our overview of the draft Guidelines here). The deadline for providing written submissions has been extended from January 20, 2020 to January 31, 2020. The PMPRB began meeting with stakeholders to discuss the new Guidelines in early December.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.

ARTICLE
26 December 2019

PMPRB Extends Deadline For Consultation On Draft Guidelines To January 31, 2020

Canada Food, Drugs, Healthcare, Life Sciences
Contributor
Smart & Biggar is Canada's largest firm practicing exclusively in intellectual property and technology law, with offices in Ottawa, Toronto, Montréal, Vancouver and Calgary. We are leaders in intellectual property and have been serving clients for over a century. Intellectual property rights are only valuable if they can be protected and exploited intelligently. At Smart & Biggar we are devoted to maximizing the value of our clients' intellectual property and technology assets. While we are proud that we have been selected repeatedly as Canada's leading intellectual property firm in numerous Canadian and international surveys, we recognize that our success is best measured by your success. Smart & Biggar operates as part of the IPH Limited group, under its own brand and independent from other IPH member firms. For more information, please visit https://www.smartbiggar.ca/
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More